TPST•benzinga•
Tempest Therapeutics Director Thomas Woiwode Reported Purchase of 2,118,644 Shares @ Avg Price of $2.36/Share in Form 4 Filing on Tuesday
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga